Cancer Tissue Study

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Scottsdale/Phoenix, Arizona: 2130-00
    • Rochester, Minnesota: 2130-00
    Sponsor Protocol Number: 2130-00

About this study

The goal of this study is to create a comprehensive system of tissue/serum banking of samples from Mayo Clinic Arizona patients with a diagnosis of cancer, inheritable cancer syndrome, at high risk for an inheritable cancer syndrome based on genetic counselor assessment, or a high risk pre-malignant lesion who have undergone a surgical procedure to remove the cancer or high risk tissue.  This study is being done to collect blood and tissue samples for future research of cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Patient Eligibility

  • Participation in this study comprises a collection of tissue from the patient’s surgical procedure and blood that is drawn around the time of the patient’s surgery. 
  • However, there are times when a subsequent surgery, or surgeries, is indicated, and if tissue is removed during a subsequent surgery, any available tissue following pathologic evaluation may also be saved for this study.
  • Eligible patients are those patients at Mayo Clinic Arizona with a diagnosis of cancer who have a surgical procedure to remove the cancer.
  • Patients must sign the informed consent to have blood drawn or any tissue saved.

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Barbara Pockaj, M.D.

Open for enrollment

Contact information:

Patricia Dyer

(480)342-4325

dyer.patricia@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Barbara Pockaj, M.D.

Closed for enrollment

Contact information:

No Contact

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions